Leveraging ELISA and PCR for Potency Assay Development in AAV-Related Gene Therapy to Aid Comparability
Time: 2:15 pm
day: Conference Day One
Details:
- Exploring challenges in characterizing and analyzing AAV-related gene therapy products
- Designing ELISA-based assays for quantifying AAV vector titers and assessing their functional activity
- Strategies for designing PCR-based assays to validate gene expression and therapeutic payload delivery
